SCHEMBL4097733

SCHEMBL4097733

Cc1ccc(-n2cc(CO)c(C(C)C)n2)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PANK3 Q9H999 1/20 0.34
EGLN1 Q9GZT9 2/20 0.32
CPB2 Q96IY4 2/20 0.32
BRD4 O60885 1/20 0.32
OGA O60502 1/20 0.32
EGLN2 Q96KS0 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
TP53 P04637 1/20 0.31
PKM P14618 1/20 0.31
STAT3 P40763 1/20 0.31
STAT1 P42224 1/20 0.31
GRIN2D O15399 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27719755 0.76 ACVR2A (0.36) NPC1RAB9AMEN1KMT2APANK3
SCHEMBL6035787 0.73 CYP11B1 (0.34) MEN1KMT2APANK3EGLN1OGA
SCHEMBL6035380 0.72 CNR1 (0.39) NPC1RAB9AMEN1KMT2APANK3
SCHEMBL6036094 0.71 SMN1; SMN2 (0.41) NPC1RAB9AMEN1KMT2APANK3
SCHEMBL6035090 0.70 KDM4E (0.39) PANK3EGLN1KDM4EALDH1A1
SCHEMBL6035571 0.70 KCNJ1 (0.44) KMT2AEGLN1MAPTHRH3
SCHEMBL6034887 0.70 CNR1 (0.37) NPC1RAB9APANK3OGASMN1; SMN2
SCHEMBL6035785 0.70 GCGR (0.41) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6035102 0.70 CNR1 (0.37) NPC1RAB9APANK3OGASMN1; SMN2
SCHEMBL6036247 0.69 SMN1; SMN2 (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta NIPPON CHEMIPHAR CO., LTD. (JP) 2009-09-24 US disclosed
EP-1854784-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2007-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta PPARG, PPARA, PPARD NPC1 1565/4885RAB9A 2637/4885MEN1 4821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.